Yes. Uncontrolled hypertension, commonly called uncontrolled high blood pressure, is a contraindication for Contrave. The FDA-approved prescribing information says Contrave should not be used in that situation. The same label calls for blood pressure and pulse to be measured before treatment and checked regularly during treatment, especially for people whose hypertension is controlled with a plan.
What a contraindication means for Contrave
A contraindication is stronger than a routine precaution. It identifies a situation in which a medication should not be used because the potential risk is unacceptable. For Contrave, the FDA-approved prescribing information lists uncontrolled hypertension under Contraindications. That is why a current blood-pressure reading belongs in the prescribing decision before the first tablet is taken.
Contrave is an extended-release oral prescription medicine that combines naltrexone hydrochloride and bupropion hydrochloride. It is used with a reduced-calorie eating plan and increased physical activity for chronic weight management in eligible adults. The combination matters here because bupropion-containing medicines can affect blood pressure and heart rate. The label notes that Contrave can raise systolic or diastolic blood pressure and resting heart rate.
“Uncontrolled” is not a label someone should apply to themselves from one stressful day or a single home reading. It describes a clinical state that needs to be assessed in context, including repeated readings, current treatment, symptoms, other health conditions, and the reliability of the measurement. The safe takeaway is simple: Contrave is not a medication to start while blood pressure is uncontrolled.
Controlled hypertension still changes the prescribing plan
Controlled hypertension and uncontrolled hypertension are not interchangeable. A person whose blood pressure is controlled may still be considered for Contrave, but the label directs prescribers to measure blood pressure and pulse before treatment and at regular intervals. That monitoring is particularly relevant for people with controlled hypertension because a change after starting treatment can alter the risk-benefit balance.
The timing matters. In the clinical studies summarized in the label, differences in blood pressure between people taking Contrave and people taking placebo were most notable in the first 12 weeks. That does not predict any one person’s response. It does explain why the first weeks are not a period for guessing, skipping follow-up, or changing the dose independently.
A useful medication review looks at the full picture, not only the number on the cuff. It includes the current blood-pressure plan, the medicines already used for blood pressure, recent readings, sleep, alcohol use, and symptoms such as dizziness, palpitations, severe headache, or chest discomfort. Those details can point to a safer next step before another weight-management medication is added.
Contrave has other contraindications that must be screened
Uncontrolled hypertension is one item on a longer safety list. The FDA label also lists seizure disorders; current or prior anorexia nervosa or bulimia; abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs; use of other bupropion-containing products; chronic opioid use; use of a monoamine oxidase inhibitor within the prior 14 days; and a known allergy to a Contrave ingredient.
These details are not interchangeable. Naltrexone blocks opioid receptors, so ongoing opioid use and opioid withdrawal change the safety picture. Bupropion can lower the seizure threshold, so seizure history, eating-disorder history, abrupt withdrawal from certain substances, and other bupropion medicines need to be considered before treatment. A complete list of prescriptions, over-the-counter medicines, vitamins, and supplements helps identify conflicts that a medication name alone can miss.
The label also recommends avoiding high-fat meals with Contrave because they can increase systemic exposure to its components. That is one example of why dose, timing, food, and other medicines belong in the same prescribing conversation. A tablet is not a stand-alone plan.
Opioid use needs a specific conversation before Contrave
Opioids can appear in more places than a long-term pain prescription. Some cough, cold, and diarrhea medicines contain an opioid. Opioid treatment programs and medicines used to treat opioid use disorder also matter. Because Contrave contains naltrexone, the label lists chronic opioid use as a contraindication and warns that starting it after recent opioid exposure can trigger sudden opioid withdrawal.
The label describes an opioid-free interval of at least 7 to 10 days before starting Contrave for people previously dependent on short-acting opioids. The needed interval can be longer for people transitioning from buprenorphine or methadone. That timing is not a do-it-yourself schedule. It depends on the medicine involved, the last use, and the treatment plan, which is why every opioid-containing product belongs on the medication list before Contrave is considered.
Starting dose and follow-up are planned, not improvised
Contrave is started on a step-up schedule, not at its full maintenance dose on day one. The FDA label begins with one tablet in the morning during week 1, adds an evening tablet in week 2, and reaches two tablets in the morning and two in the evening in week 4. The staged schedule is intended to reduce risk while the prescribing clinician follows tolerability, blood pressure, pulse, and other safety information.
Response also has a defined review point. The label directs prescribers to evaluate response after 12 weeks at the maintenance dose and discontinue Contrave if a patient has not lost at least 5% of baseline body weight, because meaningful sustained weight loss is unlikely. That standard keeps the decision focused on measurable benefit as well as safety. A medication that is technically available but not helping enough is not automatically the right long-term plan.
Coverage and prescribing safety are separate decisions
Insurance approval, a savings offer, or a pharmacy price does not override a contraindication. Those are access questions. The decision to prescribe Contrave still begins with whether the medication fits the person’s health history, current medicines, blood-pressure status, and follow-up needs. Keeping those decisions separate prevents an avoidable mistake: treating an available medication as though it is automatically an appropriate one.
That distinction also helps when a plan requires prior authorization. Prior authorization is an insurer’s coverage process, not a medical clearance. The information supplied for coverage may overlap with a clinical record, but an insurance decision does not replace the medication review, blood-pressure measurement, or monitoring described in the prescribing information. The order matters: establish safety and clinical fit first, then work through the coverage details that apply to the chosen plan.
Blood-pressure monitoring is part of safe follow-up
A reliable blood-pressure check uses a properly sized cuff, a seated rest period, and a repeat measurement when a reading is unexpectedly high. The American Heart Association’s home-monitoring guidance explains why cuff size and technique affect the value of a home reading. Recording the date, time, reading, pulse, symptoms, and medicines taken that day creates a much clearer starting point than trying to remember a number later.
Some symptoms require urgent medical care, regardless of whether Contrave is involved. Chest pain, sudden severe shortness of breath, fainting, new weakness or numbness on one side, trouble speaking, sudden vision changes, or a sudden severe headache can signal an emergency. The CDC’s stroke-symptoms guidance says to call 9-1-1 right away for sudden signs of stroke. Those symptoms should not be watched at home or treated as a routine medication side effect.
For non-emergency changes in blood pressure or pulse after a prescription starts, the prescribing plan guides the next step. Do not increase, reduce, stop, restart, or combine a prescription weight-management medicine based on a reading alone. Medication changes can affect blood pressure, mood, seizure risk, opioid response, and other parts of care at the same time.
Questions that make a Contrave review more useful
Bring current information rather than a general description. A practical medication review can include recent blood-pressure and pulse readings, the name and dose of every prescription, over-the-counter product, vitamin, and supplement, any opioid-containing medicine used for pain, cough, or diarrhea, and changes in alcohol or sedative use. Pregnancy plans, kidney or liver concerns, mood history, and prior seizures also belong in the record because they may change whether Contrave is a reasonable option.
The goal is not to clear a checklist so that one specific medication can be prescribed. It is to determine whether Contrave is an appropriate option now, whether blood pressure needs attention first, or whether another approach makes more sense. A careful review protects against two common problems: starting a medication despite a contraindication and overlooking a more suitable care plan.
How Resolve approaches Contrave decisions
Resolve offers clinician-guided medical weight-loss care, including information on Contrave treatment for eligible adults. The practice reviews medical history, current medicines, goals, and safety considerations before deciding whether a medication belongs in a plan. Blood pressure, opioid use, mood history, and seizure risk are part of that work because they can change the answer.
Patients can also review Resolve’s information about insurance verification and the existing guide to Contrave coverage and prior authorization. Coverage does not establish that a medication is safe or appropriate. Clinical fit comes first, then the practical questions around access and follow-up.
Frequently asked questions
Is uncontrolled high blood pressure a contraindication for Contrave?
Yes. The FDA-approved prescribing information lists uncontrolled hypertension as a contraindication. That means Contrave should not be used when blood pressure is uncontrolled. A prescribing clinician needs current blood-pressure information before deciding whether the medication is appropriate.
Can someone with controlled high blood pressure take Contrave?
Controlled high blood pressure is not the same as uncontrolled hypertension, but it still requires an individual prescribing decision. The prescribing information calls for blood pressure and pulse to be measured before treatment and monitored regularly, particularly for people with controlled hypertension.
Why does Contrave require a medication review?
Contrave contains naltrexone and bupropion. The label lists several situations where it should not be used, including chronic opioid use, other bupropion-containing products, seizure disorders, certain eating disorders, and recent use of an MAOI. A complete medication and health-history review helps identify those issues before a prescription is started.
Should I stop Contrave if my blood pressure reading is high?
Do not change a prescription on your own. A high reading needs prompt clinical guidance because the meaning depends on the number, symptoms, your usual readings, and the rest of your health history. Seek emergency care for symptoms that could signal a medical emergency, such as chest pain, severe shortness of breath, weakness on one side, trouble speaking, or a sudden severe headache.
Related posts
Does Insurance Cover Contrave?
What coverage rules, prior authorization, and pharmacy costs can mean for your next step.
Read the article →
Phentermine Alternatives: Options to Discuss
How health history and safety factors can shape a medication decision.
Read the article →Contrave product image is from CONTRAVE® by Currax Pharmaceuticals LLC.
This article is for general education and does not replace medical advice from a clinician who knows your health history. Do not start, stop, combine, or change a prescription weight-management medicine without clinical guidance.